Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Lisa E Gralinski
Affiliation
University of North Carolina at Chapel Hill
ORCID
Career Start Year
2002
Papers
77
H Index
46
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
35194605
A model of persistent post SARS-CoV-2 induced lung disease for target identification and testing of therapeutic strategies.
bioRxiv
2022
35654851
Targeted isolation of diverse human protective broadly neutralizing antibodies against SARS-like viruses.
Nat Immunol
2022
35931818
Understanding COVID-19-associated coagulopathy.
Nat Rev Immunol
2022
35677067
A Multitrait Locus Regulates Sarbecovirus Pathogenesis.
bioRxiv
2022
35862771
A Multitrait Locus Regulates Sarbecovirus Pathogenesis.
mBio
2022
35357886
A modified vaccinia Ankara vaccine expressing spike and nucleocapsid protects rhesus macaques against SARS-CoV-2 Delta infection.
Sci Immunol
2022
35857635
SARS-CoV-2 infection produces chronic pulmonary epithelial and immune cell dysfunction with fibrosis in mice.
Sci Transl Med
2022
35291291
Broadly neutralizing anti-S2 antibodies protect against all three human betacoronaviruses that cause severe disease.
bioRxiv
2022
35194605
A model of persistent post SARS-CoV-2 induced lung disease for target identification and testing of therapeutic strategies.
bioRxiv
2022
35677067
A Multitrait Locus Regulates Sarbecovirus Pathogenesis.
bioRxiv
2022
35857635
SARS-CoV-2 infection produces chronic pulmonary epithelial and immune cell dysfunction with fibrosis in mice.
Sci Transl Med
2022
35862771
A Multitrait Locus Regulates Sarbecovirus Pathogenesis.
mBio
2022
35357886
A modified vaccinia Ankara vaccine expressing spike and nucleocapsid protects rhesus macaques against SARS-CoV-2 Delta infection.
Sci Immunol
2022
35654851
Targeted isolation of diverse human protective broadly neutralizing antibodies against SARS-like viruses.
Nat Immunol
2022
35931818
Understanding COVID-19-associated coagulopathy.
Nat Rev Immunol
2022
35291291
Broadly neutralizing anti-S2 antibodies protect against all three human betacoronaviruses that cause severe disease.
bioRxiv
2022
33469219
Publisher Correction: A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasures.
Nature
2021
34013261
Common Mechanism of SARS-CoV and SARS-CoV-2 Pathogenesis across Species.
bioRxiv
2021
34117252
SARS-CoV-2 RBD trimer protein adjuvanted with Alum-3M-052 protects from SARS-CoV-2 infection and immune pathology in the lung.
Nat Commun
2021
33469219
Publisher Correction: A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasures.
Nature
2021
34159335
Protective efficacy of rhesus adenovirus COVID-19 vaccines against mouse-adapted SARS-CoV-2.
bioRxiv
2021
33513210
Baseline T cell immune phenotypes predict virologic and disease control upon SARS-CoV infection in Collaborative Cross mice.
PLoS Pathog
2021
33561864
SARS-CoV-2 infection is effectively treated and prevented by EIDD-2801.
Nature
2021
34334300
Coagulation and wound repair during COVID-19.
J Heart Lung Transplant
2021
33495307
Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibody.
Science
2021
34523968
Protective Efficacy of Rhesus Adenovirus COVID-19 Vaccines against Mouse-Adapted SARS-CoV-2.
J Virol
2021
34372702
Unfolded Protein Response Inhibition Reduces Middle East Respiratory Syndrome Coronavirus-Induced Acute Lung Injury.
mBio
2021
33495307
Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibody.
Science
2021
33513210
Baseline T cell immune phenotypes predict virologic and disease control upon SARS-CoV infection in Collaborative Cross mice.
PLoS Pathog
2021
33561864
SARS-CoV-2 infection is effectively treated and prevented by EIDD-2801.
Nature
2021
34523968
Protective Efficacy of Rhesus Adenovirus COVID-19 Vaccines against Mouse-Adapted SARS-CoV-2.
J Virol
2021
34159335
Protective efficacy of rhesus adenovirus COVID-19 vaccines against mouse-adapted SARS-CoV-2.
bioRxiv
2021
34013261
Common Mechanism of SARS-CoV and SARS-CoV-2 Pathogenesis across Species.
bioRxiv
2021
34117252
SARS-CoV-2 RBD trimer protein adjuvanted with Alum-3M-052 protects from SARS-CoV-2 infection and immune pathology in the lung.
Nat Commun
2021
34372702
Unfolded Protein Response Inhibition Reduces Middle East Respiratory Syndrome Coronavirus-Induced Acute Lung Injury.
mBio
2021
34334300
Coagulation and wound repair during COVID-19.
J Heart Lung Transplant
2021
31621854
Immune Predictors of Mortality After Ribonucleic Acid Virus Infection.
J Infect Dis
2020
31801868
Trypsin Treatment Unlocks Barrier for Zoonotic Bat Coronavirus Infection.
J Virol
2020
32348764
Complex Genetic Architecture Underlies Regulation of Influenza-A-Virus-Specific Antibody Responses in the Collaborative Cross.
Cell Rep
2020
31621854
Immune Predictors of Mortality After Ribonucleic Acid Virus Infection.
J Infect Dis
2020
31991541
Return of the Coronavirus: 2019-nCoV.
Viruses
2020
32931734
A Single-Dose Intranasal ChAd Vaccine Protects Upper and Lower Respiratory Tracts against SARS-CoV-2.
Cell
2020
32526206
SARS-CoV-2 Reverse Genetics Reveals a Variable Infection Gradient in the Respiratory Tract.
Cell
2020
33139569
Rapid identification of a human antibody with high prophylactic and therapeutic efficacy in three animal models of SARS-CoV-2 infection.
Proc Natl Acad Sci U S A
2020
33031744
A Mouse-Adapted SARS-CoV-2 Induces Acute Lung Injury and Mortality in Standard Laboratory Mice.
Cell
2020
33236009
An Engineered Antibody with Broad Protective Efficacy in Murine Models of SARS and COVID-19.
bioRxiv
2020
33184236
SARS-CoV-2 D614G variant exhibits efficient replication ex vivo and transmission in vivo.
Science
2020
33024969
SARS-CoV-2 D614G Variant Exhibits Enhanced Replication ex vivo and Earlier Transmission in vivo.
bioRxiv
2020
32854108
A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasures.
Nature
2020
32511409
Potently neutralizing human antibodies that block SARS-CoV-2 receptor binding and protect animals.
bioRxiv
2020
1 - 50 of 154
Column Actions
Search
Recommended Authors
Santos Bermejo
Yale University
Career Start Year
2018
Number of shared co-authors
0
Laura Martin-Sancho
The Scripps Research Institute
Career Start Year
2018
Number of shared co-authors
1
Tianyang Mao
Yale University School of Medicine
Career Start Year
2017
Number of shared co-authors
0
James Logue
Center for Pathogen Research, University of Maryland School of Medicine
Career Start Year
2017
Number of shared co-authors
9
Camille R Simoneau
Gladstone Institute of Virology
Career Start Year
2015
Number of shared co-authors
2
Nagarjuna R Cheemarla
Yale School of Medicine
Career Start Year
2015
Number of shared co-authors
0
Raveen Rathnasinghe
Icahn School of Medicine at Mount Sinai New York
Career Start Year
2015
Number of shared co-authors
2
Soner Yildiz
University of Geneva
Career Start Year
2014
Number of shared co-authors
1
David Sachs
Icahn School of Medicine at Mount Sinai
Career Start Year
2013
Number of shared co-authors
0
Ann-Kathrin Reuschl
University College London
Career Start Year
2013
Number of shared co-authors
0
Peiwen Lu
Yale University School of Medicine
Career Start Year
2013
Number of shared co-authors
0
R??my Robinot
Institut Pasteur, Universite Paris Cite, CNRS UMR 9
Career Start Year
2012
Number of shared co-authors
0
Shashank Tripathi
Indian Institute of Science
Career Start Year
2011
Number of shared co-authors
4
Benjamin Israelow
Yale University School of Medicine
Career Start Year
2010
Number of shared co-authors
0
Craig B Wilen
Yale School of Medicine
Career Start Year
2010
Number of shared co-authors
4
Carles Mart??nez-Romero
Icahn School of Medicine at Mount Sinai
Career Start Year
2009
Number of shared co-authors
1
Benjamin T Bradley
University of Washington
Career Start Year
2009
Number of shared co-authors
0
Siyuan Ding
Washington University School of Medicine
Career Start Year
2009
Number of shared co-authors
2
Judd F Hultquist
Northwestern University Feinberg School of Medicine
Career Start Year
2008
Number of shared co-authors
2
Hans-Heinrich Hoffmann
The Rockefeller University
Career Start Year
2008
Number of shared co-authors
3
Nicholas S Heaton
Duke University School of Medicine
Career Start Year
2006
Number of shared co-authors
5
Amber M Smith
University of California san francisco
Career Start Year
2006
Number of shared co-authors
4
Emmie de Wit
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Career Start Year
2004
Number of shared co-authors
10
Benjamin R tenOever
NYU Grossman School of Medicine
Career Start Year
2001
Number of shared co-authors
6
Luis Martinez-Sobrido
Texas Biomedical Research Institute
Career Start Year
2001
Number of shared co-authors
9
Charles S Dela Cruz
Department of Microbial Pathogenesis Yale University New Haven
Career Start Year
1998
Number of shared co-authors
1
Ellen F Foxman
Yale School of Medicine
Career Start Year
1997
Number of shared co-authors
0
Shelly J Robertson
National Institute of Allergy and Infectious Diseases
Career Start Year
1995
Number of shared co-authors
8
Lucy Thorne
University College London
Career Start Year
1992
Number of shared co-authors
1
Akiko Iwasaki
Yale University
Career Start Year
1990
Number of shared co-authors
5
row(s) 1 - 30 of 30
Collaborators
Ralph S Baric
University of North Carolina
Co-authored papers
66
Vineet D Menachery
University of Texas Medical Branch
Co-authored papers
30
Alexandra Sch??fer
University of North Carolina at Chapel Hill
Co-authored papers
29
Sarah R Leist
University of North Carolina at Chapel Hill
Co-authored papers
25
Martin T Ferris
University of North Carolina.
Co-authored papers
23
Mark T Heise
University of North Carolina at Chapel Hill.
Co-authored papers
19
Boyd L Yount
University of North Carolina at Chapel Hill
Co-authored papers
17
Rachel L Graham
University of North Carolina
Co-authored papers
16
Fernando Pardo-Manuel de Villena
University of North Carolina
Co-authored papers
15
Michael G Katze
University of Washington
Co-authored papers
15
Shannon K McWeeney
Oregon Health & Science University, University of California Berkeley
Co-authored papers
12
Katrina M Waters
Pacific Northwest National Laboratory
Co-authored papers
12
Darla R Miller
The University of North Carolina at Chapel Hill
Co-authored papers
11
Sudhakar Agnihothram
National Center for Toxicological Research
Co-authored papers
11
Amy C Sims
The University of North Carolina at Chapel Hill
Co-authored papers
9
Yoshihiro Kawaoka
Influenza Research Institute, University of Wisconsin
Co-authored papers
9
Stephanie A Montgomery
and Lineberger Comprehensive Cancer Center, University of North Carolina System
Co-authored papers
9
Scott H Randell
Co-authored papers
9
Alan C Whitmore
University of North Carolina at Chapel Hill
Co-authored papers
9
Ande West
University of North Carolina at Chapel Hill
Co-authored papers
8
Richard C Boucher
Co-authored papers
8
Hugh D Mitchell
Pacific Northwest National Laboratory (PNNL)
Co-authored papers
8
Richard D Smith
Pacific Northwest National Laboratory
Co-authored papers
7
Laurence Josset
Institut des Agents Infectieux, Infective Agents Institute, North Hospital Network
Co-authored papers
7
Kenichi Okuda
Co-authored papers
7
Thomas O Metz
Pacific Northwest National Laboratory
Co-authored papers
7
Amie J Eisfeld
Influenza Research Institute, University of Wisconsin-Madison
Co-authored papers
7
Timothy A Bell
University of North Carolina
Co-authored papers
7
Bobbie-Jo M Webb-Robertson
Pacific Northwest National Laboratory
Co-authored papers
6
Richard Green
Center for Innate Immunity and Immune Disease, University of Washington
Co-authored papers
6
1 - 30